Bristol-Myers Squibb Company (BVMF:BMYB34)

Brazil flag Brazil · Delayed Price · Currency is BRL
252.01
-33.00 (-11.58%)
At close: Jul 4, 2025, 4:55 PM GMT-3
16.77%
Market Cap 517.05B
Revenue (ttm) 273.12B
Net Income (ttm) 31.07B
Shares Out n/a
EPS (ttm) 15.31
PE Ratio 16.64
Forward PE 7.17
Dividend 9.25 (3.67%)
Ex-Dividend Date Jul 3, 2025
Volume 12
Average Volume 58
Open 256.18
Previous Close 285.01
Day's Range 252.01 - 256.18
52-Week Range 203.15 - 369.03
Beta 0.39
RSI 43.73
Earnings Date Jul 31, 2025

About BVMF:BMYB34

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Sector Healthcare
Founded 1887
Employees 34,100
Stock Exchange Brazil Stock Exchange
Ticker Symbol BMYB34
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.